Lars‐Goran Carlsson

Risks of Pneumonia in Patients with Asthma Taking Inhaled Corticosteroids

Paul M. O’Byrne, Søren Pedersen, Lars‐Goran Carlsson et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 115 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Budesonide/formoterol maintenance and reliever therapy via <scp>T</scp>urbuhaler versus fixed‐dose budesonide/formoterol plus terbutaline in patients with asthma: Phase <scp>III</scp> study results

Tito Atienza, Teresita O. Aquino, Marcelo Fernández et al. · Respirology · 2012 · 39 citations

Pharmacy, Pharmacotherapy, Allergy +16

Budesonide/formoterol via <scp>T</scp>urbuhaler® versus formoterol via <scp>T</scp>urbuhaler® in patients with moderate to severe chronic obstructive pulmonary disease: Phase <scp>III</scp> multinational study results

Yoshinosuke Fukuchi, Ronnie Samoro, Hiroyuki Taniguchi et al. · Respirology · 2013 · 28 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide

Karine Clearie, Peter A. Williamson, Karen T. Meldrum et al. · British Journal of Clinical Pharmacology · 2010 · 27 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Budesonide Inhalation Suspension Versus Montelukast in Children Aged 2 to 4 Years with Mild Persistent Asthma

Stanley J. Szefler, Lars‐Goran Carlsson, Tom Uryniak et al. · The Journal of Allergy and Clinical Immunology In Practice · 2012 · 23 citations · Full text

Pharmacy, Pediatrics, Pharmacotherapy +16